Anti-monocyte chemoattractant protein-1 gene therapy for cardiovascular diseases (Q35696305)

9 August 2017

1 reference

title

Anti-monocyte chemoattractant protein-1 gene therapy for cardiovascular diseases (English)

1 reference

9 August 2017

0 references

cardiovascular disease

1 reference

Shiro Kitamoto

1

1 reference

PubMed ID

15030267

9 August 2017

Kensuke Egashira

series ordinal

2

1 reference

9 August 2017

1 September 2003

1 reference

Expert Review of Cardiovascular Therapy

9 August 2017

1 reference

9 August 2017

1

1 reference

9 August 2017

3

1 reference

9 August 2017

393-400

1 reference

Atherosclerosis — An Inflammatory Disease

9 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.3.393

Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.3.393

Evidence of impaired endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.3.393

Clinical importance of endothelial function in arteriosclerosis and ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.3.393

Probucol attenuates left ventricular dysfunction and remodeling in tachycardia-induced heart failure: roles of oxidative stress and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.3.393

Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.3.393

Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.3.393

Local overexpression of monocyte chemoattractant protein-1 at vessel wall induces infiltration of macrophages and formation of atherosclerotic lesion: synergism with hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.3.393

Tissue factor is induced by monocyte chemoattractant protein-1 in human aortic smooth muscle and THP-1 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.3.393

Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.3.393

JE mRNA accumulates rapidly in aortic injury and in platelet-derived growth factor-stimulated vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.3.393

Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.3.393

CCR2 deficiency decreases intimal hyperplasia after arterial injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.3.393

What is "the matter" with restenosis in 2002?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.3.393

Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.3.393

Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.3.393

Essential role of monocyte chemoattractant protein-1 in development of restenotic changes (neointimal hyperplasia and constrictive remodeling) after balloon angioplasty in hypercholesterolemic rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.3.393

Molecular mechanisms mediating inflammation in vascular disease: special reference to monocyte chemoattractant protein-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.3.393

Chemokine receptor CCR2 is expressed by human multiple myeloma cells and mediates migration to bone marrow stromal cell-produced monocyte chemotactic proteins MCP-1, -2 and -3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.3.393

Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.3.393

Passive Smoking and Impaired Endothelium-Dependent Arterial Dilatation in Healthy Young Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.3.393

Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.3.393

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.3.393

Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation: long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.3.393

Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.3.393

Pathology of Acute and Chronic Coronary Stenting in Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.1.3.393

21 January 2018

Identifiers

DOI

10.1586/14779072.1.3.393

1 reference

9 August 2017

1 reference

PubMed ID

15030267